Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Clinical Perfectionism in Parkinson Disease (EPMP-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02824367
Recruitment Status : Unknown
Verified August 2018 by Centre Hospitalier Universitaire, Amiens.
Recruitment status was:  Active, not recruiting
First Posted : July 6, 2016
Last Update Posted : August 21, 2018
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire, Amiens

Brief Summary:
Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety.

Condition or disease Intervention/treatment Phase
Parkinson Disease Behavioral: Completion of scales evaluation Not Applicable

Detailed Description:

Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety. Also, clinicians reported that they exhibit specific personality traits (e.g., rigidity and perfectionism).

To date, few studies used Cognitive Behavioural Therapies (CBT) in people with Parkinson's disease showing promising results. Recently, perfectionism has received particular attention because of it association with many emotional disorders. Thus, some psychometric tools have been developed in order to evaluate different aspects of perfectionism. Yet, none of them has been used in people with Parkinson's disease.

The objective of this study is to investigate whether there is a direct link between Parkinson's disease and perfectionism by using psychometric tools from the CBT literature. Identifying such link would allow to justify the use of CBT in people with Parkinson's disease with the goal in mind to improve their care and quality of life.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Evaluation of Clinical Perfectionism in Parkinson Disease
Actual Study Start Date : October 6, 2014
Estimated Primary Completion Date : August 2018
Estimated Study Completion Date : August 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Parkinsonian
Patient Arm: Parkinsonian will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Behavioral: Completion of scales evaluation
Patient complete scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS), Hewitt Multidimensional Perfectionism Scale (HMPS), scores to depression scale (Beck Depression Inventory (BDI)) and anxiety scale (State Trait Anxiety Inventory (STAI))

Dystonic
Comparator Arm: Dystonic patient will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Behavioral: Completion of scales evaluation
Patient complete scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS), Hewitt Multidimensional Perfectionism Scale (HMPS), scores to depression scale (Beck Depression Inventory (BDI)) and anxiety scale (State Trait Anxiety Inventory (STAI))




Primary Outcome Measures :
  1. Perfectionism evaluation 1 [ Time Frame: Day 0 ]
    Scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS)

  2. Perfectionism evaluation 2 [ Time Frame: Day 0 ]
    Hewitt Multidimensional Perfectionism Scale (HMPS).


Secondary Outcome Measures :
  1. Depression and anxiety evaluation 1 [ Time Frame: Day 0 ]
    Scores to depression scale (Beck Depression Inventory (BDI))

  2. Depression and anxiety evaluation 2 [ Time Frame: Day 0 ]
    anxiety scale (State Trait Anxiety Inventory (STAI))



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age greater than 18 years
  • Score Mini Mental Scale (MMS) greater than 23
  • For Parkinsonian, Parkinson disease be defined according to the criteria of the Unified Parkinson Disease Rating Scale (UPDRS), with a Hoehn and Yahr stage 1, 2 or 3
  • The control patients present dystonias not within the scope of Parkinson
  • Informed Consent Form signed
  • Patient covered by social insurance

Exclusion Criteria:

  • Proven Presence of neuropsychological disorders
  • Patients with deep brain stimulation
  • Diagnosis of somatic pathology diagnosed
  • Private Patient freedom or protected adult (under guardianship)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02824367


Locations
Layout table for location information
France
CHU Amiens
Amiens, France, 80054
Sponsors and Collaborators
Centre Hospitalier Universitaire, Amiens
Investigators
Layout table for investigator information
Principal Investigator: Pierre KRYSTKOWIAK, MD, PhD CHU Amiens
Layout table for additonal information
Responsible Party: Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier: NCT02824367    
Other Study ID Numbers: PI2014_843_0002
2013-A01302-43 ( Other Identifier: ID-RCB )
First Posted: July 6, 2016    Key Record Dates
Last Update Posted: August 21, 2018
Last Verified: August 2018
Keywords provided by Centre Hospitalier Universitaire, Amiens:
Parkinson
Perfectionism
Additional relevant MeSH terms:
Layout table for MeSH terms
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases